Loci specific epigenetic drug sensitivity

Thanutra Zhang1, Anna Pilko1,2, Roy Wollman1,2

  • 1Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA.

Insights

New platform reveals locus-specific drug sensitivities for epigenetic modulators (epi-drugs). This advances understanding of how epi-drugs affect gene expression, paving the way for targeted therapies.

Area of Science:

  • Epigenetics and Genomics
  • Chemical Biology
  • Drug Discovery

Background:

  • Therapeutic targeting of epigenetic modulators (epi-drugs) presents a novel treatment strategy for various diseases.
  • The precise mechanisms underlying cellular changes induced by epi-drugs remain unclear, particularly the extent of global versus locus-specific effects.

Purpose of the Study:

  • To develop a platform for systematically investigating epi-drug sensitivity at numerous genomic locations.
  • To differentiate between cell-wide and disease-related locus-specific effects of epi-drugs.

Main Methods:

  • Combined DNA barcoding, unique split-pool encoding, and single-cell expression measurements.
  • Integrated internal controls to isolate locus-specific effects from global drug consequences.
  • Leveraged ENCODE data on chromatin modification.

Main Results:

  • Discovered widespread locus-specific sensitivities to three distinct epi-drugs targeting histone deacetylase, DNA methylation, and bromodomain proteins.
  • Identified specific chromatin environment features susceptible to epi-drug action.
  • Demonstrated the platform's capability to simultaneously assess hundreds of genomic locations.

Conclusions:

  • Locus-specific drug sensitivities are prevalent and predictable based on chromatin features.
  • This platform enables precise measurement of epi-drug effects, crucial for developing targeted therapies.
  • Findings support the advancement of personalized medicine through tailored epigenetic drug treatments.

Related Concept Videos

Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
351
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.3K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K